Vaccines can protect us well beyond their intended role in remarkable and often unexpected ways, says Lisa Jarvis for ...
RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback